{"id":747450,"date":"2026-07-07T00:18:18","date_gmt":"2026-07-07T00:18:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/747450\/"},"modified":"2026-07-07T00:18:18","modified_gmt":"2026-07-07T00:18:18","slug":"worried-about-ozempic-butt-new-drug-could-stop-muscle-loss-tied-to-weight-loss-injections","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/747450\/","title":{"rendered":"Worried about &#8216;Ozempic butt?&#8217; New drug could stop muscle loss tied to weight loss injections"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/07\/gettyimages-2279484867-scaled.jpg\" alt=\"\" width=\"764\" height=\"432\" loading=\"eager\" fetchpriority=\"high\" data-v-653d32e2=\"\"\/> article <\/p>\n<p data-v-653d32e2=\"\">FILE: GLP-1 weight loss medications (Photo by: Michael Siluk\/UCG\/Universal Images Group via Getty Images) <\/p>\n<p data-v-94395e58=\"\">A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.\u00a0<\/p>\n<p data-v-94395e58=\"\">The drug, called apitegromab, was featured in a new study published in\u00a0<a href=\"https:\/\/www.nature.com\/articles\/s41591-026-04440-4\" rel=\"nofollow noopener\" target=\"_blank\">Nature Medical<\/a> journal.\u00a0<\/p>\n<p> What is \u2018Ozempic butt?\u2019  <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">The backstory:<\/p>\n<p data-v-94395e58=\"\">\u00a0&#8220;Ozempic butt&#8221; refers to the loss of muscle that people on weight loss injections can experience when they <a href=\"https:\/\/www.livenowfox.com\/tag\/health\" target=\"_blank\" rel=\"noopener nofollow\">lose weight quickly without strength training<\/a> and regular exercise. Some people on the drugs have reported flatter butts and loose skin as unwanted side effects.\u00a0<\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">By the numbers:<\/p>\n<p data-v-94395e58=\"\">Some research suggests up to 30% of weight loss in GLP-1 patients is lean muscle, not fat, though newer studies say over time, the majority of weight loss in GLP-1 patients is fat, not muscle.\u00a0<\/p>\n<p data-v-94395e58=\"\">RELATED: <a href=\"https:\/\/www.livenowfox.com\/news\/medicare-glp-1-drug-program-what-know\" target=\"_blank\" rel=\"noopener nofollow\">Medicare rolls out $50 GLP-1 drug program: What to know<\/a><\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">Why you should care:<\/p>\n<p data-v-94395e58=\"\">Experts say it\u2019s harder to regain muscle than it is to regain fat.\u00a0<\/p>\n<p> What is apitegromab?\u00a0 <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">Big picture view:<\/p>\n<p data-v-94395e58=\"\">According to the study, apitegromab is a drug that &#8220;selectively inhibits&#8221; the activation of myostatin, a protein that helps to break down muscle.\u00a0<\/p>\n<p data-v-94395e58=\"\">RELATED: <a href=\"https:\/\/www.livenowfox.com\/news\/glp-1-drugs-blood-pressure-risks-certain-patients-study\" target=\"_blank\" rel=\"noopener nofollow\">GLP-1 drugs tied to blood pressure risks in certain patients, study finds<\/a><\/p>\n<p data-v-94395e58=\"\">In a trial of 102 adults, more than 80% of whom were women, those who were given apitegromab as a supplement to GLP-1 treatment saw &#8220;significantly reduced lean mass loss,&#8221; the study found. After six months, those taking apitegromab lost an average of 3.5 pounds of lean muscle mass, compared to 7.7 pounds for those taking the placebo.\u00a0<\/p>\n<p data-v-94395e58=\"\">According to\u00a0<a href=\"https:\/\/www.bbc.com\/news\/articles\/c62r285l46eo\" rel=\"nofollow noopener\" target=\"_blank\">BBC<\/a>, apitegromab is only available for use in clinical trials. It\u2019s administered as an infusion through a vein.\u00a0<\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">What&#8217;s next:<\/p>\n<p data-v-94395e58=\"\">Doctors said the early results were promising, but cautioned that more studies are needed.<\/p>\n<p data-v-94395e58=\"\">Scholar Rock, the company tha tmakes it, hopes the drug can eventually be given as a self-injection pen like many GLP-1 drugs currently on the market.\u00a0<\/p>\n<p> How to prevent muscle loss while taking GLP-1 drugs <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">What you can do:<\/p>\n<p data-v-94395e58=\"\"><a href=\"https:\/\/advances.massgeneral.org\/endocrinology\/article.aspx?id=1601\" rel=\"nofollow noopener\" target=\"_blank\">Doctors at Massachusetts General Hospital<\/a> say people on GLP-1 drugs should follow a high-protein diet and get regular exercise, including strength training, to prevent muscle loss.\u00a0<\/p>\n<p class=\"group-source-paragraph\" data-v-4fbf7207=\"\">The Source: This report includes information from Nature Medical journal, BBC and Massachusetts General Hospital.<\/p>\n<p>    <a href=\"https:\/\/www.livenowfox.com\/tag\/health-care\" class=\"tags-tag\" data-v-94395e58=\"\" rel=\"nofollow noopener\" target=\"_blank\">Health Care<\/a><a href=\"https:\/\/www.livenowfox.com\/tag\/health\" class=\"tags-tag\" data-v-94395e58=\"\" rel=\"nofollow noopener\" target=\"_blank\">Health<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"article FILE: GLP-1 weight loss medications (Photo by: Michael Siluk\/UCG\/Universal Images Group via Getty Images) A new drug&hellip;\n","protected":false},"author":2,"featured_media":747451,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[97,252,243,3],"class_list":["post-747450","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-health-care","tag-medication","tag-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/747450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=747450"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/747450\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/747451"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=747450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=747450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=747450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}